Skip to Content

Mettler-Toledo International Inc MTD

Morningstar Rating
$1,286.54 +18.56 (1.46%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Mettler-Toledo Earnings: 2023 Revenue and 2024 Guidance Challenged by Weak Market Conditions

We are maintaining our $880 fair value estimate for narrow-moat Mettler-Toledo as fourth-quarter and full-year 2023 results were about as expected. Following the January announcement of shipping delays impacting sales late in the fourth quarter, we updated our model to temper our 2023 revenue and adjusted EPS forecasts while lifting our respective 2024 forecasts to reflect the anticipated recovery in sales in first-quarter 2024. Shares currently look overvalued relative to our unchanged valuation.

Price vs Fair Value

MTD is trading at a 46% premium.
Price
$1,286.54
Fair Value
$845.00
Uncertainty
Medium
1-Star Price
$2,491.00
5-Star Price
$235.00
Economic Moat
Ccntt
Capital Allocation
Wwfptnrc

Bulls Say, Bears Say

Bulls

Despite the slow market growth of balances, Mettler has consistently produced double-digit earnings growth with its marketing and efficiency initiatives along with share repurchases.

Bears

Mettler’s large share-buyback program could be destroying shareholder value, with the firm continually adding leverage to buy back what we view as overpriced stock.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MTD is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$1,267.98
Day Range
$1,262.941,300.01
52-Week Range
$928.501,615.97
Bid/Ask
$0.00 / $1,573.97
Market Cap
$27.63 Bil
Volume/Avg
165,341 / 147,373

Key Statistics

Price/Earnings (Normalized)
33.79
Price/Sales
7.46
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
3.26%

Company Profile

Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences, industrial, and food retail industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with sales distribution roughly as follows: United States around 30% of sales, Europe around 30%, China around 20%, and the rest of the world around 20%.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Mid Core
Total Number of Employees
17,300

Competitors

Valuation

Metric
MTD
SRT3
DHR
Price/Earnings (Normalized)
33.79123.9530.07
Price/Book Value
11.643.54
Price/Sales
7.463.547.97
Price/Cash Flow
30.9120.0027.66
Price/Earnings
MTD
SRT3
DHR

Financial Strength

Metric
MTD
SRT3
DHR
Quick Ratio
0.620.621.18
Current Ratio
1.041.471.68
Interest Coverage
13.593.6317.58
Quick Ratio
MTD
SRT3
DHR

Profitability

Metric
MTD
SRT3
DHR
Return on Assets (Normalized)
24.53%4.16%5.68%
Return on Equity (Normalized)
16.78%9.47%
Return on Invested Capital (Normalized)
44.03%6.93%6.69%
Return on Assets
MTD
SRT3
DHR
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncPtyf$221.8 Bil
DHR
Danaher CorpTbjqbh$189.5 Bil
IDXX
IDEXX Laboratories IncRrjqgz$47.4 Bil
IQV
IQVIA Holdings IncRlnwcgk$45.8 Bil
A
Agilent Technologies IncWldp$41.9 Bil
ICLR
Icon PLCSrqnhhg$27.3 Bil
ILMN
Illumina IncPwtcpv$21.9 Bil
WAT
Waters CorpXqx$20.5 Bil
LH
Laboratory Corp of America HoldingsFplcqg$18.4 Bil

Sponsor Center